Although the understanding of amylin’s functions and its potential contribution to migraines and pain disorders is still evolving, altogether these findings tend to highlight the possibility of different involvement of CGRP and amylin pathways among different migraine patients, providing a rationale for the development of molecules that selectively target amylin pathway. The gene discussed is CALCA; the disease is migraine disorder.